Figure 2

Kaplan-Meier analysis for RFS by recurrence risks defined by logistic regression risk model. Patients defined as high recurrence risk (dashed line) by the logistic regression model demonstrated significantly reduced RFS compared to patients defined as low recurrence risk (solid line) in both the (A) discovery (p < 0.0001 by log rank test) and (B) validation (p = 0.033 by log rank test) cohorts